Behshad Sheldon
President Camurus Inc
Behshad Sheldon (born 1963) was appointed President of Camurus Inc in 2024 and holds the overall responsibility for leading Camurus’ organization in the US.
She has more than 25 years of experience from leading positions within the international pharmaceutical industry, including as President & CEO of Braeburn Pharmaceuticals up to 2017, and from senior positions within Smithkline Beecham, Bristol-Myers Squibb and Otsuka Pharmaceuticals, where she led successful blockbuster brands such as Glucophage, Plavix, and Abilify. Most recently Behshad was a Managing Director at Biotech Value Advisors where she supported biotech and pharmaceutical companies with pre-launch and commercialization efforts in the US.
Behshad holds a B.Sc. in Neuroscience from University of Rochester.
Other current appointments: Chairwoman at Female Opioid Research & Clinical Experts (FORCE), Board member at Maxona Pharmaceuticals and Egetis Therapeutics.
Holdings: 1,000 shares, 2,000 employee options and 2,918 Performance Share Plan units.